JP2008531693A - 局所用ゲル組成物 - Google Patents
局所用ゲル組成物 Download PDFInfo
- Publication number
- JP2008531693A JP2008531693A JP2007558091A JP2007558091A JP2008531693A JP 2008531693 A JP2008531693 A JP 2008531693A JP 2007558091 A JP2007558091 A JP 2007558091A JP 2007558091 A JP2007558091 A JP 2007558091A JP 2008531693 A JP2008531693 A JP 2008531693A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- nsaid
- alcohol
- amount
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65808405P | 2005-03-03 | 2005-03-03 | |
| US68110205P | 2005-05-13 | 2005-05-13 | |
| US69020105P | 2005-06-14 | 2005-06-14 | |
| US11/361,384 US20070053984A1 (en) | 2005-03-03 | 2006-02-24 | Topical gels compositions |
| PCT/US2006/006780 WO2006096360A1 (en) | 2005-03-03 | 2006-02-27 | Topical gels compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008531693A true JP2008531693A (ja) | 2008-08-14 |
| JP2008531693A5 JP2008531693A5 (cg-RX-API-DMAC7.html) | 2009-04-09 |
Family
ID=42334238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007558091A Pending JP2008531693A (ja) | 2005-03-03 | 2006-02-27 | 局所用ゲル組成物 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1858503B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008531693A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20080008321A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006220964A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0608077A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2599968A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2437201T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL185531A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007010681A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006096360A1 (cg-RX-API-DMAC7.html) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011106846A (ja) * | 2009-11-13 | 2011-06-02 | Hamamatsu Univ School Of Medicine | 新規nsaid潰瘍リスク判定方法 |
| JP2014513132A (ja) * | 2011-05-03 | 2014-05-29 | アポニア ラボラトリーズ インコーポレイテッド | イブプロフェンの経皮組成物およびその使用方法 |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7914814B2 (en) | 1997-09-17 | 2011-03-29 | Strategic Science & Technologies, Llc | Topical delivery of arginine of cause beneficial effects |
| AU2005235308B2 (en) | 2004-04-19 | 2011-12-01 | Strategic Science & Technologies, Llc | Transdermal delivery of beneficial substances effected by a hostile biophysical environment |
| US9226909B2 (en) | 2004-04-19 | 2016-01-05 | Strategic Science & Technologies, Llc | Beneficial effects of increasing local blood flow |
| US20080317684A1 (en) * | 2006-09-06 | 2008-12-25 | Isw Group, Inc. | Topical Compositions |
| CA2666398C (en) | 2006-10-17 | 2015-08-18 | Ed Kisak | Diclofenac gel |
| ES2316312B1 (es) * | 2008-06-20 | 2010-02-08 | Ignacio Umbert Millet | Composicion farmaceutica dermatologica para el tratamiento de patologias de inflamacion de la piel, tales como por ejemplo dermatitis, dermatitis atopica, vitiligo, alopecia areata, acne, psoriasis y prurito,y combinaciones de las mismas. |
| US8618164B2 (en) | 2009-03-31 | 2013-12-31 | Nuvo Research Inc. | Treatment of pain with topical diclofenac compounds |
| US8546450B1 (en) | 2009-03-31 | 2013-10-01 | Nuvo Research Inc. | Treatment of pain with topical diclofenac compounds |
| AU2009348470B2 (en) * | 2009-06-24 | 2015-04-02 | Strategic Science & Technologies, Llc | Topical composition containing ibuprofen |
| US11684624B2 (en) | 2009-06-24 | 2023-06-27 | Strategic Science & Technologies, Llc | Treatment of erectile dysfunction and other indications |
| EP2445493A1 (en) * | 2009-06-24 | 2012-05-02 | Strategic Science & Technologies, LLC | Topical composition containing naproxen |
| US12138268B2 (en) | 2009-06-24 | 2024-11-12 | Strategic Science & Technologies, Llc | Treatment of erectile dysfunction and other indications |
| AU2015203547B2 (en) * | 2009-06-24 | 2017-05-18 | Strategic Science & Technologies, Llc | Topical composition containing ibuprofen |
| KR101141938B1 (ko) * | 2010-01-22 | 2012-05-04 | 성균관대학교산학협력단 | 신규한 항생제 조성물 및 그람양성균의 치료 방법 |
| JP2014504592A (ja) | 2010-12-29 | 2014-02-24 | ストラテジック サイエンス アンド テクノロジーズ, エルエルシー | 勃起不全および他の適応症の処置 |
| JP2014501283A (ja) | 2010-12-29 | 2014-01-20 | ストラテジック サイエンス アンド テクノロジーズ, エルエルシー | アレルギーおよび他の適応症の処置のためのシステムおよび方法 |
| EP3113849B1 (en) | 2014-02-26 | 2019-06-12 | Luma Therapeutics, Inc. | Ultraviolet phototherapy apparatus |
| KR20180134856A (ko) | 2016-02-09 | 2018-12-19 | 루마 세러퓨틱스 인코포레이티드 | 광선요법에 의해 건선을 치료하기 위한 방법, 조성물 및 장치 |
| US20200230082A1 (en) * | 2017-07-11 | 2020-07-23 | University Of Miami | Topical acetaminophen formulations for itch relief |
| US20230398060A1 (en) * | 2020-05-19 | 2023-12-14 | Mig Usa, Llc | Topical compositions and methods for treating pain |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5791913A (en) * | 1980-11-28 | 1982-06-08 | Nitto Electric Ind Co Ltd | Pharmaceutical preparation of drug |
| JPH04210914A (ja) * | 1990-01-24 | 1992-08-03 | Mcneil Ppc Inc | 水アルコール性ゲルを用いるイブプロフエンの経皮デリバリー方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1987002891A1 (en) | 1985-11-07 | 1987-05-21 | Pfizer Inc. | Compounds and method for the topical treatment of inflammation and pain |
| US5639738A (en) | 1992-02-20 | 1997-06-17 | Hyal Pharmaceutical Corporation | Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs |
| US5976566A (en) | 1997-08-29 | 1999-11-02 | Macrochem Corporation | Non-steroidal antiinflammtory drug formulations for topical application to the skin |
-
2006
- 2006-02-27 EP EP06736159.2A patent/EP1858503B1/en not_active Not-in-force
- 2006-02-27 AU AU2006220964A patent/AU2006220964A1/en not_active Abandoned
- 2006-02-27 WO PCT/US2006/006780 patent/WO2006096360A1/en not_active Ceased
- 2006-02-27 CA CA002599968A patent/CA2599968A1/en not_active Abandoned
- 2006-02-27 ES ES06736159.2T patent/ES2437201T3/es active Active
- 2006-02-27 KR KR1020077022557A patent/KR20080008321A/ko not_active Withdrawn
- 2006-02-27 MX MX2007010681A patent/MX2007010681A/es not_active Application Discontinuation
- 2006-02-27 JP JP2007558091A patent/JP2008531693A/ja active Pending
- 2006-02-27 BR BRPI0608077-4A patent/BRPI0608077A2/pt not_active IP Right Cessation
-
2007
- 2007-08-27 IL IL185531A patent/IL185531A0/en unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5791913A (en) * | 1980-11-28 | 1982-06-08 | Nitto Electric Ind Co Ltd | Pharmaceutical preparation of drug |
| JPH04210914A (ja) * | 1990-01-24 | 1992-08-03 | Mcneil Ppc Inc | 水アルコール性ゲルを用いるイブプロフエンの経皮デリバリー方法 |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011106846A (ja) * | 2009-11-13 | 2011-06-02 | Hamamatsu Univ School Of Medicine | 新規nsaid潰瘍リスク判定方法 |
| JP2014513132A (ja) * | 2011-05-03 | 2014-05-29 | アポニア ラボラトリーズ インコーポレイテッド | イブプロフェンの経皮組成物およびその使用方法 |
| US10821071B2 (en) | 2011-05-03 | 2020-11-03 | Aponia Laboratories, Inc. | Transdermal compositions of ibuprofen and methods of use thereof |
| US11419814B2 (en) | 2011-05-03 | 2022-08-23 | Aponia Laboratories, Inc. | Transdermal compositions of ibuprofen and methods of use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006220964A1 (en) | 2006-09-14 |
| CA2599968A1 (en) | 2006-09-14 |
| IL185531A0 (en) | 2008-01-06 |
| BRPI0608077A2 (pt) | 2009-11-10 |
| EP1858503B1 (en) | 2013-09-04 |
| EP1858503A1 (en) | 2007-11-28 |
| WO2006096360A1 (en) | 2006-09-14 |
| MX2007010681A (es) | 2007-12-07 |
| KR20080008321A (ko) | 2008-01-23 |
| ES2437201T3 (es) | 2014-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20100158993A1 (en) | Topical Gel Compositions | |
| EP1858503B1 (en) | Topical gels compositions | |
| CA2662434C (en) | Topical nsaid compositions with increased solubility | |
| AU670777B2 (en) | Aqueous gel vehicles for retinoids | |
| US20140314815A1 (en) | Adhesive solid gel-forming formulations for dermal drug delivery | |
| US8815953B2 (en) | Formulations of vitamin K analogs for topical use | |
| JP2000501429A (ja) | 局所治療用および化粧用製剤の組成物基剤 | |
| US20050137164A1 (en) | Diclofenac compositions for the treatment of skin disorders | |
| US20110281947A1 (en) | Methods of administering diclofenac compositions for treating photodamaged skin | |
| Salau et al. | Enhancement of transdermal permeation of cannabinoids and their pharmacodynamic evaluation in rats | |
| KR20210053946A (ko) | 피내 적용을 위한 신규한 국소 제형 및 그것의 용도 | |
| ZA200707357B (en) | Detection of very virulent infectious bursal disease virus | |
| CN101541321A (zh) | 局部用组合物 | |
| CN101151028A (zh) | 局部用凝胶组合物 | |
| HK1119058A (en) | Topical gels compositions | |
| RU2809702C2 (ru) | Композиции напроксена для местного применения в форме геля |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090220 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090220 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120117 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120703 |